Stenocare A/S (CPH:STENO)
1.625
+0.025 (1.56%)
At close: Dec 5, 2025
Stenocare Market Cap
Stenocare has a market cap or net worth of 70.19 million as of December 5, 2025. Its market cap has increased by 73.92% in one year.
Market Cap
70.19M
Enterprise Value
68.10M
Revenue
5.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.63
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 70.19M, a decrease of -78.52%. That is a compound annual growth rate of -24.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 70.19M | 170.25% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | 223.96M | -31.48% |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.38T |
| Coloplast | 130.98B |
| Genmab | 125.17B |
| ALK-Abelló | 50.39B |
| Demant | 46.10B |
| H. Lundbeck | 42.41B |
| Zealand Pharma | 35.71B |
| Ambu A/S | 23.26B |